Editas Medicine, Inc. (EDIT)
- Previous Close
1.3900 - Open
1.4200 - Bid 1.3000 x 600
- Ask 1.8100 x 200
- Day's Range
1.4100 - 1.5300 - 52 Week Range
0.9100 - 6.6900 - Volume
1,051,487 - Avg. Volume
3,703,458 - Market Cap (intraday)
121.387M - Beta (5Y Monthly) 2.15
- PE Ratio (TTM)
-- - EPS (TTM)
-2.8800 - Earnings Date May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.67
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
www.editasmedicine.comRecent News: EDIT
View More
Performance Overview: EDIT
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EDIT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EDIT
View MoreValuation Measures
Market Cap
116.36M
Enterprise Value
-118.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.54
Price/Book (mrq)
0.87
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-35.52%
Return on Equity (ttm)
-98.10%
Revenue (ttm)
32.31M
Net Income Avi to Common (ttm)
-237.09M
Diluted EPS (ttm)
-2.8800
Balance Sheet and Cash Flow
Total Cash (mrq)
269.91M
Total Debt/Equity (mrq)
26.09%
Levered Free Cash Flow (ttm)
-121.09M
Research Analysis: EDIT
View MoreResearch Reports: EDIT
View MoreDaily – Vickers Top Buyers & Sellers for 01/05/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 03/08/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 03/05/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.